dr. landen discusses p53 mutations in ovarian cancer
Published 5 years ago • 648 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:35
dr. landen on molecular subtypes of ovarian cancer
-
1:23
dr. memarzadeh on p53 reactivation in ovarian cancer
-
1:13
dr. mccann on resistance mutations in ovarian cancer
-
1:25
dr. chern on important germline and somatic mutations in ovarian cancer
-
1:20
dr. brown on germline and somatic testing in ovarian cancer
-
0:42
dr. zsiros discusses pembrolizumab triplet in recurrent ovarian cancer
-
1:40
dr. moore on immunotherapy and parp combinations in brca-mutated ovarian cancer
-
1:54
dr. o’malley on maintenance rucaparib in non-brca hrr-mutated in ovarian cancer
-
7:30
somatic mutation testing for ovarian cancer
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
1:26
dr. penson on biomarkers of response to parp inhibitors in ovarian cancer
-
1:15
dr. rule on treatment approaches for patients with p53-mutated mcl
-
1:20
dr. ledermann discusses olaparib in ovarian cancer
-
1:15
dr. hays on targeting mutations in gynecologic cancers
-
0:12
copy of dr. mccann on resistance mutations in ovarian cancer
-
1:21
dr. sessa on the management of brca1/2 mutations in ovarian cancer
-
1:22
dr. bobbie j. rimel on genetic testing in ovarian cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer
-
1:25
dr. borst on homologous recombination deficiency in patients with ovarian cancer